Skip to end of metadata
Go to start of metadata

Each year, about 6 million of the 65 million pet dogs in the United States will be diagnosed with spontaneous, naturally occurring cancer. Of the 32 million pet cats, 6 million will be diagnosed with cancer. Pet animals with naturally occurring cancers are traditionally treated by veterinary oncologists in private practices or at teaching hospitals, using therapies similar to those used in humans, including surgery, chemotherapy, radiation therapy, and biotherapy. The inclusion of this large number of animals suffering from cancer in the study of human cancer is referred to as comparative oncology. Comparative oncology brings together the work of veterinary clinical oncologists with medical oncologists, the pharmaceutical industry, and academic centers involved in cancer research. The product of this effort is an improved understanding of the biology of cancer and improved treatment options for both animals and humans afflicted with cancer.

Here are some links for more information on individual canine cancers:

More Information and Related News for Tumor Types:

  • “Bone Cancer Vaccine for Dogs Shows Promise for Breast Cancer.” Nov. 21, 2013
  • “Canine Cancer Studies Yield Human Insights.” Feb. 8 2012
  • “Researchers at Huntsman Cancer Institute say modified viruses show promise in treating melanoma.” April 1, 2015

  • “Personalized Cancer Vaccine Enters Human Trials.” September 17, 2013
  • “3-D Photography Helps Early Detection in Patients at High Risk for Melanoma.” March 17, 2015

  • “Hemangiosarcoma Trial Will Determine Efficacy of Promising Toxin Therapy.” January 2014

  • “Compound Derived From a Mushroom Lengthens Survival Time in Dogs With Cancer, Penn Vet Study Finds.” September 10, 2012

For more news and publications see News & Publications





  • No labels